✦ LIBER ✦

PCV53 COST-UTILITY ANALYSIS OF EPROSARTAN COMPARED TO ENALAPRIL AND RAMIPRIL IN THE TREATMENT OF MODERATE TO SEVERE HYPERTENSION IN SWEDEN

✍ Scribed by P Lindgren; B Schwander; Y Zöllner; B Jönsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV17 A COST-UTILITY ANALYSIS OF LOSARTA

✍ AH Anis; H Sun; S Singh; JC Woolcott; B Nosyk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Cost-Utility Analysis of Eprosartan Comp

✍ Björn Schwander; Birgit Gradl; York Zöllner; Peter Lindgren; Hans-Christoph Dien 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

PCV4: COST ANALYSIS OF AMLODIPINE VERSUS

✍ E Berliner; P Radensky 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV54 THE COST-UTILITY OF ALISKIREN IN T

✍ A Lee; SJ Barry; L Leiter; A Nanji; L Annemans; D Tucker; AF Michaliszyn; M Barb 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PSS27 A COST-UTILITY ANALYSIS OF ETANERC

✍ Di Matteo, S; Colombo, GL 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Combination of ramipril and hydrochlorot

✍ D. Heidbreder; K.-L. Froer; A. Breitstadt; V. Cairns; N. Bender; A. Langley 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB